AavantiBio, Inc.
SEC Form D private-offering issuer in Biotechnology
Operating in sec form d - biotechnology based in GAINESVILLE, FLORIDA, AavantiBio, Inc. was founded in 2019.
Profile
Private US issuer recorded in the SEC Form D structured dataset for 2020Q4. Industry: Biotechnology. Revenue range: Decline to Disclose. Offering amount: 106856458.
As a business in sec form d - biotechnology, AavantiBio, Inc. is listed here with the public details available about it.
The company is recorded as being based in GAINESVILLE, FLORIDA.
It is recorded at the Regulation D stage.
Recorded headcount: 51-200 employees.
Total disclosed funding stands at about $106.9M.
| Sector | SEC Form D - Biotechnology |
|---|---|
| Headquarters | GAINESVILLE, FLORIDA |
| Country | United States |
| Founded | 2019 |
| Employees | 51-200 |
| Stage | Regulation D |
| Total funding | $106,856,458 |
Website: aavantibio.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account